Anti-IgE Drug Scratches Itch of Chronic Hives (CME/CE)

BALTIMORE (MedPage Today) -- The anti-immunoglobulin E (IgE) monoclonal antibody omalizumab (Xolair) durably eased itch severity in chronic urticaria uncontrolled by antihistamines, a pivotal trial showed.
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news